AI assistant
PVH CORP. /DE/ — Director's Dealing 2023
Dec 15, 2023
31157_dirs_2023-12-15_d4ea0baf-71ec-4e18-bb61-2b8e5a3e4edf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PVH CORP. /DE/ (PVH)
CIK: 0000078239
Period of Report: 2023-12-13
Reporting Person: HAGMAN MARTIJN (CEO TH Global/PVH Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-13 | Common Stock, $1 par value | S | 1856 | $110.88 | Disposed | 49514 | Direct |
| 2023-12-14 | Common Stock, $1 par value | M | 8025 | $71.51 | Acquired | 57539 | Direct |
| 2023-12-14 | Common Stock, $1 par value | M | 4425 | $67.05 | Acquired | 61964 | Direct |
| 2023-12-14 | Common Stock, $1 par value | M | 6450 | $50.17 | Acquired | 68414 | Direct |
| 2023-12-14 | Common Stock, $1 par value | S | 18900 | $115.69 | Disposed | 49514 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-14 | Option (Right to Buy) | $71.51 | M | 8025 | Disposed | 2032-04-06 | Common Stock, $1 par value (8025) | Direct |
| 2023-12-14 | Option (Right to Buy) | $67.05 | M | 4425 | Disposed | 2030-09-10 | Common Stock, $1 par value (4425) | Direct |
| 2023-12-14 | Option (Right to Buy) | $50.17 | M | 6450 | Disposed | 2030-06-15 | Common Stock, $1 par value (6450) | Direct |
Footnotes
F1: Includes 26,174 shares of Common Stock subject to unvested awards of restricted stock units and 2,452 shares of Common Stock subject to unvested performance share units.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.64 to $116.05 inclusive. The reporting person undertakes to provide to the Issuer any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: Options to acquire 8,025 shares become exercisable on each of 4/6/2023, and options to exercise a further 8,025 shares will become exercisable on each of 4/6/2024, 4/6/2025 and 4/6/2026.
F4: Options to acquire 1,475 shares became exercisable on each of 9/10/2021, 9/10/2022 and 9/10/2023, and options to exercise a further 1,475 shares will become exercisable on 9/10/2024.
F5: Options to acquire 2,150 shares became exercisable on each of 6/15/2021, 6/15/2022 and 6/15/2023, and options to exercise a further 2,150 shares will become exercisable on 6/15/2024.